<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T02:16:27Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/134269" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/134269</identifier><datestamp>2026-03-25T00:45:57Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress</dc:title>
   <dc:creator>Mac-Dowell Mata, Karina Soledad</dc:creator>
   <dc:creator>Caso Fernández, Javier Rubén</dc:creator>
   <dc:creator>David Martín-Hernández</dc:creator>
   <dc:creator>Beatriz M. Moreno</dc:creator>
   <dc:creator>José L. M. Madrigal</dc:creator>
   <dc:creator>Muñoz Madrigal, José Luis</dc:creator>
   <dc:creator>Juan A. Micó</dc:creator>
   <dc:creator>Leza Cerro, Juan Carlos</dc:creator>
   <dc:creator>García Bueno, Borja</dc:creator>
   <dc:subject>616.895.8</dc:subject>
   <dc:subject>Antioxidant enzymes</dc:subject>
   <dc:subject>Antipsychotics</dc:subject>
   <dc:subject>IL-10; M2 microglia</dc:subject>
   <dc:subject>NRF2</dc:subject>
   <dc:subject>Restraint stress</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>32 Ciencias Médicas</dc:subject>
   <dc:description>Alterations in the innate inflammatory response may underlie the pathophysiology of psychiatric diseases. Current antipsychotics modulate pro-/anti-inflammatory pathways, but their specific actions on these pathways remain only partly explored. This study was conducted to elucidate the regulatory role of paliperidone (1 mg/kg i.p.) on acute (6 h) and chronic (6 h/day for 21 consecutive days) restraint stress-induced alterations in 2 emerging endogenous anti-inflammatory/antioxidant mechanisms: nuclear factor erythroid-related factor 2 (NRF2)/antioxidant enzymes pathway, and the cytokine milieu regulating M1/M2 polarization in microglia, analyzed at the mRNA and protein levels in prefrontal cortex samples. In acute stress conditions, paliperidone enhanced NRF2 levels, possibly related to phosphoinositide 3-kinase upregulation and reduced kelch-Like ECH-associated protein 1 expression. In chronic conditions, paliperidone tended to normalize NRF2 levels through a phosphoinositide 3-kinase related-mechanism, with no effects on kelch-Like ECH-associated protein 1. Antioxidant response element-dependent antioxidant enzymes were upregulated by paliperidone in acute stress, while in chronic stress, paliperidone tended to prevent stress-induced downregulation of the endogenous antioxidant machinery. However, paliperidone increased transforming growth factor-β and interleukin-10 in favor of an M2 microglia profile in acute stress conditions, which was also corroborated by paliperidone-induced increased levels of the M2 cellular markers arginase I and folate receptor 2. This latter effect was also produced in chronic conditions. Immunofluorescence studies suggested an increase in the number of microglial cells expressing arginase I and folate receptor 2 in the stressed animals pretreated with paliperidone. In conclusion, the enhancement of endogenous antioxidant/anti-inflammatory pathways by current and new antipsychotics could represent an interesting therapeutic strategy for the future.</dc:description>
   <dc:description>Depto. de Farmacología y Toxicología</dc:description>
   <dc:description>Fac. de Medicina</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2026-03-24T15:56:45Z</dc:date>
   <dc:date>2026-03-24T15:56:45Z</dc:date>
   <dc:date>2016-04-27</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/134269</dc:identifier>
   <dc:identifier>XXXX-XXXX</dc:identifier>
   <dc:identifier>10.1007/s13311-016-0438-2</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>MacDowell KS, Caso JR, Martín-Hernández D, Moreno BM, Madrigal JLM, Micó JA, Leza JC, García-Bueno B. The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress. Neurotherapeutics. 2016 Oct;13(4):833-843. doi: 10.1007/s13311-016-0438-2. PMID: 27233514; PMCID: PMC5081131.</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>